Delta Modtech to showcase transdermal converting and coating machine at AACC

Delta ModTech® offers innovative solutions for manufacturing a variety of complex medical, pharmaceutical, label, security, RFID, packaging and cosmetic products. A Delta ModTech Crusader® converter will be running a transdermal type product during the show. The system will feature a variety of processes including rotary die cutting, embossing and precise part placement. This unique system is designed to offer precision parts while minimizing waste of expensive materials. Other Delta ModTech systems may include capabilities such as semi-rotary, full rotary and laser cutting as well as heat seal pouching. Delta ModTech is dedicated to providing precise, flexible and innovative manufacturing solutions worldwide.

In addition at AACC we will feature the Frontier® Mobile Coat Unit. The combination of Delta ModTech and Frontier offers experience and innovation for our customers. Delta ModTech's engineering support and manufacturing capabilities complement Frontier's expertise in coating and drying systems. This partnership improves solutions for customers across the diagnostics, transdermal, electrode, wound care, medical, pharmaceutical, security, label, and consumer industries.

Visit us in booth 3363, engineers will be on site to confidentially discuss your specific application requirements and help you develop a total solution. Delta ModTech systems are custom designed and engineered to meet your application requirements, improve your profitability, and reduce your risk.

Source:

2016 AACC Annual Meeting Press Program

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Avadel Pharmaceuticals announces publication of RESTORE data highlighting challenges with twice-nightly oxybates and strong patient preference for once-nightly LUMRYZ™ dosing (sodium oxybate) extended-release oral suspension (CIII)